Breaking News Instant updates and real-time market news.

NUS

Nu Skin

$69.58

0.985 (1.44%)

16:50
02/13/19
02/13
16:50
02/13/19
16:50

Nu Skin sees Q1 EPS 70c-77c, consensus 75c

Sees Q1 revenue $615M-$635M, consensus $625.56M.

  • 13

    Feb

  • 28

    Feb

  • 06

    Mar

NUS Nu Skin
$69.58

0.985 (1.44%)

10/09/18
DADA
10/09/18
INITIATION
Target $92
DADA
Buy
Nu Skin initiated with a Buy at DA Davidson
DA Davidson analyst Linda Bolton Weiser initiated Nu Skin (NUS) with a Buy rating and a price target of $92, forecasting a 13% organic sales growth and 24% earnings growth in FY18. The analyst notes the achievements of the company's new CEO and CFO in shifting its focus to customer acquisition through "engaging Platforms that leverage social selling, enabling Products that are demonstrable online, and empowering programs to optimize sales performance." Weiser also points to Nu Skin's attractive valuation at 9.0-times her expected FY19 EBITDA - a discount to Herbalife (HLF) and USANA (USNA) which trade around 11-times.
10/10/18
10/10/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Take-Two (TTWO) initiated with an Outperform at Bernstein. 2. Shake Shack (SHAK) initiated with a Hold at Stifel. 3. Nu Skin (NUS) initiated with a Buy at DA Davidson. 4. Micron (MU) initiated with a Neutral at Piper Jaffray. 5. Crispr Therapeutics (CRSP) initiated with an Outperform at Wells Fargo. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/21/18
TIGR
11/21/18
NO CHANGE
TIGR
Strong Buy
Nu Skin pullback a buying opportunity, says Tigress Financial
Tigress Financial analyst Ivan Feinseth said he views the recent pullback in shares of Nu Skin as a buying opportunity, citing his belief that the company will continue to benefit from the growing global trend of entrepreneurialism and the global aging population. He reiterates his Strong Buy rating on Nu Skin shares.
12/12/18
DADA
12/12/18
NO CHANGE
Target $88
DADA
Buy
Nu Skin price target lowered to $88 from $92 at DA Davidson
DA Davidson analyst Linda Bolton Weiser lowered her price target on Nu Skin to $88 after meeting with its CFO Mark Lawrence in a Holiday Beauty Bus Tour. The analyst states that while he was upbeat about the company's 3-pillar growth strategy around "Platforms, Products, and Programs", her lower price target is driven by the assumption of lower 2019 gross margins as the company's "lower margin manufacturing operations are likely to grow faster than the overall business". Weiser also lowers her FY19 EPS view by 15c to $4.00 but maintains a Buy rating on Nu Skin shares longer term on expectations that the company will gradually phase out its "limited time offers", thereby reducing the lumpiness of its sales growth rate.

TODAY'S FREE FLY STORIES

CENX

Century Aluminum

$9.30

0.12 (1.31%)

17:31
02/21/19
02/21
17:31
02/21/19
17:31
Earnings
Century Aluminum reports Q4 EPS (43c), consensus (53c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EXEL

Exelixis

$21.22

(0.00%)

17:30
02/21/19
02/21
17:30
02/21/19
17:30
Initiation
Exelixis initiated  »

Exelixis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPSN

Epsilon Energy

$0.00

(0.00%)

17:30
02/21/19
02/21
17:30
02/21/19
17:30
Hot Stocks
Epsilon Energy sees 2019 production growth of 27%-33% y/y »

The company anticipates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSRM

SSR Mining

$14.13

0.245 (1.76%)

17:29
02/21/19
02/21
17:29
02/21/19
17:29
Earnings
SSR Mining sees FY19 gold production 395,000 equivalent ounces »

At the Marigold mine,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ENPH

Enphase Energy

$7.37

0.13 (1.80%)

17:29
02/21/19
02/21
17:29
02/21/19
17:29
Hot Stocks
Park West Asset Management reports 5.4% passive stake in Enphase Energy »

Park West Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

EPSN

Epsilon Energy

$0.00

(0.00%)

17:29
02/21/19
02/21
17:29
02/21/19
17:29
Hot Stocks
Epsilon Energy board approves $20M-$25M capital budget for 2019 »

Epsilon Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSRM

SSR Mining

$14.13

0.245 (1.76%)

17:28
02/21/19
02/21
17:28
02/21/19
17:28
Earnings
SSR Mining reports Q4 adjusted EPS 4c, two estimates 0c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

BIIB

Biogen

$320.99

-14.02 (-4.18%)

17:28
02/21/19
02/21
17:28
02/21/19
17:28
Initiation
Biogen initiated  »

Biogen initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 28

    May

DBX

Dropbox

$25.58

0.1 (0.39%)

17:27
02/21/19
02/21
17:27
02/21/19
17:27
Earnings
Dropbox sees FY19 revenue $1.63B-$1.64B, consensus $1.6B »

Sees FY19 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

QNST

QuinStreet

$13.52

-0.26 (-1.89%)

17:26
02/21/19
02/21
17:26
02/21/19
17:26
Hot Stocks
Park West Asset Management reports 5.0% passive stake in QuinStreet »

Park West Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 27

    Mar

APPN

Appian

$38.73

0.41 (1.07%)

17:26
02/21/19
02/21
17:26
02/21/19
17:26
Earnings
Appian sees FY19 EPS (46c)-(42c), consensus (44c) »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 07

    Mar

WAB

Wabtec

$73.59

-1.425 (-1.90%)

, GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

17:26
02/21/19
02/21
17:26
02/21/19
17:26
Hot Stocks
S&P announces changes to S&P 400, 500 indices »

Wabtec (WAB) will replace…

WAB

Wabtec

$73.59

-1.425 (-1.90%)

GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

GE

General Electric

$10.03

-0.07 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

DBX

Dropbox

$25.58

0.1 (0.39%)

17:26
02/21/19
02/21
17:26
02/21/19
17:26
Earnings
Dropbox sees Q1 revenue $379M-$382M, consensus $377.03M »

Guidance taken from Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

EIDX

Eidos Therapeutics

$14.99

-0.64 (-4.09%)

17:25
02/21/19
02/21
17:25
02/21/19
17:25
Initiation
Eidos Therapeutics initiated  »

Eidos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

NOC

Northrop Grumman

$287.50

-0.73 (-0.25%)

17:25
02/21/19
02/21
17:25
02/21/19
17:25
Hot Stocks
Northrop Grumman Australia unit to continue work on F-35 program »

Northrop Grumman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

APPN

Appian

$38.73

0.41 (1.07%)

17:25
02/21/19
02/21
17:25
02/21/19
17:25
Earnings
Appian sees Q1 EPS (17c)-(16c), consensus (12c) »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 07

    Mar

APPN

Appian

$38.73

0.41 (1.07%)

17:22
02/21/19
02/21
17:22
02/21/19
17:22
Earnings
Appian reports Q4 EPS (22c), consensus (16c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 07

    Mar

PTGX

Protagonist Therapeutics

$7.32

0.16 (2.23%)

17:20
02/21/19
02/21
17:20
02/21/19
17:20
Initiation
Protagonist Therapeutics initiated  »

Protagonist Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

, WAB

Wabtec

$73.59

-1.425 (-1.90%)

17:20
02/21/19
02/21
17:20
02/21/19
17:20
Hot Stocks
Breaking Hot Stocks news story on Goodyear Tire, Wabtec »

Goodyear Tire to replace…

GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

WAB

Wabtec

$73.59

-1.425 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

WAB

Wabtec

$73.59

-1.425 (-1.90%)

, GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

17:19
02/21/19
02/21
17:19
02/21/19
17:19
Hot Stocks
Wabtec to replace Goodyear Tire in S&P 500 at open on 2/27 »

General Electric (GE) is…

WAB

Wabtec

$73.59

-1.425 (-1.90%)

GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

BEAT

BioTelemetry

$73.39

-1.98 (-2.63%)

17:19
02/21/19
02/21
17:19
02/21/19
17:19
Earnings
BioTelemetry reports Q4 EPS 56c, consensus 43c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NKTR

Nektar

$40.26

-2.76 (-6.42%)

17:18
02/21/19
02/21
17:18
02/21/19
17:18
Initiation
Nektar initiated  »

Nektar initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONE

CyrusOne

$52.44

-4.75 (-8.31%)

17:16
02/21/19
02/21
17:16
02/21/19
17:16
Recommendations
CyrusOne analyst commentary  »

CyrusOne price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 11

    Mar

  • 11

    Mar

  • 18

    Jun

PLD

Prologis

$71.03

0.77 (1.10%)

17:16
02/21/19
02/21
17:16
02/21/19
17:16
Hot Stocks
Prologis raises quarterly dividend 10% to 53c per share »

Payable on March 29 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOK

MyoKardia

$43.19

-0.43 (-0.99%)

17:14
02/21/19
02/21
17:14
02/21/19
17:14
Initiation
MyoKardia initiated  »

MyoKardia initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.